Skip to main content
无锡晶海 logo

无锡晶海 — Investor Relations & Filings

Ticker · 920547 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 300 across all filing types
Latest filing 2024-04-21 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920547

About 无锡晶海

https://www.chinaaminoacid.com/

Wuxi Jinghai Amino Acid Co., Ltd. specializes in the research, development, and large-scale production of high-purity amino acids through microbial fermentation. The company’s core product portfolio includes L-Isoleucine, L-Valine, L-Leucine, L-Proline, and L-Threonine, which serve as critical raw materials for the pharmaceutical, nutritional, and food processing sectors. Utilizing advanced biotechnological processes, the firm maintains rigorous quality control standards, holding certifications such as GMP, ISO, HALAL, and KOSHER. Its products are primarily utilized in the formulation of parenteral nutrition, specialized medical foods, and high-end supplements. The company focuses on technological innovation to optimize fermentation yields and purity levels, positioning itself as a key supplier in the global amino acid supply chain.

Recent filings

Filing Released Lang Actions
无锡晶海氨基酸股份有限公司2023年度募集资金存放与实际使用情况的鉴证报告
Regulatory Filings
2024-04-21 Chinese
关于完成工商变更登记及公司章程备案并取得营业执照的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of business registration changes and company charter filing, including obtaining a new business license. It references resolutions passed at recent extraordinary shareholders' meetings and provides details about the company's updated registration information. The document is short (1162 characters) and serves as a formal notification of completed administrative and regulatory filings rather than a detailed report or financial statement. It does not contain financial data, audit information, or management discussion. Therefore, it fits best as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2024-04-02 Chinese
上海市广发律师事务所关于无锡晶海氨基酸股份有限公司2024年第三次临时股东大会的法律意见书
Regulatory Filings
2024-03-27 Chinese
2024年第三次临时股东大会决议
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement from the 2024 third extraordinary shareholders' meeting of Wuxi Jinghai Amino Acid Co., Ltd. It details the meeting's convening, attendance, agenda items, voting results, and legal opinions. The content focuses on shareholder meeting resolutions and voting outcomes rather than financial statements or management reports. The document length is 3218 characters, which is relatively short and consistent with a formal announcement of voting results rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-03-27 Chinese
关于获得食品生产许可证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a Food Production License from a regulatory authority. It details the license specifics, the impact on the company, and a risk warning. There are no financial statements, no discussion of financial results, no mention of annual or quarterly reports, nor any indication of a meeting or voting results. The document is short (1208 characters) and serves as a regulatory announcement about a license approval. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-03-12 Chinese
关于终止经营范围变更及公司章程中经营范围条款修订的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from Wuxi Jinghai Amino Acid Co., Ltd. regarding the termination of a proposed change to the company's business scope and the corresponding amendment to the company's articles of association. It includes details about board resolutions, shareholder meetings, and regulatory approval processes. The content focuses on corporate governance and operational scope changes rather than financial results or detailed financial data. The document length is short (1890 characters) and it is a formal announcement of corporate decisions rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-03-11 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.